Evidence map›Paper›PMID 35290544›Full record

ArticleBreast cancer research and treatment2022

Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort.

Paula Santiá, Anna Jansana, Isabel Del Cura, Maria Padilla-Ruiz, Laia Domingo, Javier Louro, Mercè Comas, Teresa Sanz, Talita Duarte-Salles, Maximino Redondo and 5 more

Abstract read
In one paragraph

Article in Breast cancer research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Predictors of loss to follow-up after radiotherapy in cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Paula SantiáDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
Anna JansanaDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
Isabel Del CuraHealth Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III, Madrid, Spain.
Maria Padilla-RuizHealth Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III, Madrid, Spain.
Laia DomingoDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
Javier LouroDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
Mercè ComasDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
Teresa SanzHealth Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III, Madrid, Spain.
Talita Duarte-SallesFundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Maximino RedondoResearch Unit, Costa del Sol Hospital, Biomedical Research Institute of Málaga (IBIMA), University of Málaga, Marbella, Spain.
Berta IbañezHealth Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III, Madrid, Spain.
Alexandra Prados-TorresHealth Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III, Madrid, Spain.
Xavier CastellsDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
Maria SalaDepartment of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain. msalaserra@parcdesalutmar.cat.ORCID http://orcid.org/0000-0002-9955-8746
SURBCAN Group

Funding

Instituto de Salud Carlos III PI16/0024Instituto de Salud Carlos III PI19/00056Research Network on Health Services in Chronic Diseases RD16/001/013
6 · The paper itself

Abstract

purposeTo identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data.

methodsWe conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants.

resultsA total of 2079 LTBCS were followed up for a median of 4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 79.5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50-69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up.

conclusionWe identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival.

Indexed as

Breast NeoplasmsCancer SurvivorsAftercareAgedFemaleHumansMiddle AgedRetrospective StudiesSurvivorshipAftercareBreast neoplasmsCancer survivorsGuideline adherenceLong-term survivorsMammography

Identifiers

PMID35290544
PMCPMC9090857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.